Lana Ganoci

10PUBLICATIONS
15CO-AUTHORS
Molecular targetsMetabolic medicineCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 27, 2026
ABCG2 Genetic Variability in Drug Exposure and Toxicity: Implications for Clinical Practice.

|Nov 27, 2025
Common Methylenetetrahydrofolate Reductase Polymorphism MTHFR 677C>T (rs1801133), Plasma Homocysteine, and Non-Valvular Atrial Fibrillation in Overweight/Obese Patients: Causality Indicated by Mediation and One-Sample Mendelian Randomization Analysis.

Rea Levicki, Vladimir Trkulja, Vedran Pašara

|Feb 26, 2025
Association of rs3798220 Polymorphism with Cardiovascular Incidents in Individuals with Elevated Lp(a).

Dunja Leskovar Lemešić, Livija Šimičević, Lana Ganoci

|May 25, 2024
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?

Lana Ganoci, Jozefina Palić, Vladimir Trkulja

|Jan 13, 2023
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand?

Lucija Lešnjaković, Lana Ganoci, Ivan Bilić

|Mar 28, 2022
Rapid clearance of tacrolimus blood concentration triggered by variant pharmacogenes.

Livija Šimičević, Iva Canjuga, Lada Zibar

Pageof 2

Frequent Collaborators

6 joint publications

Livija Šimičević

4 joint publications

Vladimir Trkulja

4 joint publications

Tamara Božina

3 joint publications

Nada Božina